Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.33 |
| ▸ | TSHR | P16473 | 5/20 | 0.33 |
| ▸ | LMNA | P02545 | 4/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20988689 | 0.98 | MAPT (0.34) | MAPTTSHRLMNAKDM4EHSD17B10 | |
| SCHEMBL24914600 | 0.97 | MAPT (0.34) | MAPTTSHRLMNAKDM4EHSD17B10 | |
| SCHEMBL24914585 | 0.95 | MAPT (0.32) | MAPTTSHRLMNAKDM4EHSD17B10 | |
| SCHEMBL20988536 | 0.95 | MAPT (0.35) | MAPTTSHRLMNAKDM4EHSD17B10 | |
| SCHEMBL17809146 | 0.93 | MAPT (0.37) | MAPTTSHRLMNAKDM4EHSD17B10 | |
| SCHEMBL24914531 | 0.92 | MAPT (0.32) | MAPTTSHRLMNAKDM4EHSD17B10 | |
| SCHEMBL17809393 | 0.92 | MAPT (0.33) | MAPTTSHRLMNAKDM4EHSD17B10 | |
| SCHEMBL21365781 | 0.91 | MAPT (0.34) | MAPTTSHRLMNAKDM4EHSD17B10 | |
| SCHEMBL24914776 | 0.91 | TSHR (0.36) | MAPTTSHRLMNAKDM4EHSD17B10 | |
| SCHEMBL17809139 | 0.91 | MAPT (0.38) | MAPTTSHRLMNAKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230019297-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230019297-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | TERT, TELO2, SOD1 | MAPT 2262/4885TSHR 4718/4885LMNA 4323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.